Cardiac magnetic resonance imaging in Danon disease

Cardiology

Volumn 121, Issue 1, 2012, Pages 27-30

  Nucifora, Gaetano ^a   Miani, Daniela ^a   Piccoli, Gianluca ^a   Proclemer, Alessandro ^a  

^a SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

Author keywords

Danon disease; Hypertrophic cardiomyopathy; Magnetic resonance imaging

Indexed keywords

GADOLINIUM CHELATE; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 2;

ADOLESCENT; ADULT; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CASE REPORT; CONTRAST ENHANCEMENT; DANON DISEASE; DIAGNOSTIC VALUE; ECHOCARDIOGRAPHY; FEMALE; GENE MUTATION; HEART LEFT VENTRICLE HYPERTROPHY; HETEROZYGOTE; HUMAN; PRIORITY JOURNAL;

ADOLESCENT; CARDIOMYOPATHY, HYPERTROPHIC; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; GLYCOGEN STORAGE DISEASE TYPE IIB; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING, CINE; MIDDLE AGED;

EID: 84857481009     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000336448     Document Type: Article

References (13)

1. Boucek D, Jirikowic J, Taylor M: Natural history of Danon disease. Genet Med 2011; 13: 563-568.
2. Miani D, Taylor M, Mestroni L, D'Aurizio F, Finato N, Fanin M, Brigido S, Proclemer A: Sudden death associated with Danon disease in women. Am J Cardiol 2012; 109: 406-411.
3. Kwong RY, Chan AK, Brown KA, Chan CW, Reynolds HG, Tsang S, Davis RB: Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation 2006; 113: 2733-2743. (Pubitemid 43947991)
4. Choudhury L, Mahrholdt H, Wagner A, Choi KM, Elliott MD, Klocke FJ, Bonow RO, Judd RM, Kim RJ: Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2002; 40: 2156-2164. (Pubitemid 36005903)
5. Assomull RG, Prasad SK, Lyne J, Smith G, Burman ED, Khan M, Sheppard MN, Poole- Wilson PA, Pennell DJ: Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 2006; 48: 1977-1985. (Pubitemid 44738448)
6. Nucifora G, Aquaro GD, Pingitore A, Masci PG, Lombardi M: Myocardial fibrosis in isolated left ventricular non-compaction and its relation to disease severity. Eur J Heart Fail 2011; 13: 170-176.
7. Piotrowska-Kownacka D, Kownacki L, Kuch M, Walczak E, Kosieradzka A, Fidzianska A, Krolicki L: Cardiovascular magnetic resonance findings in a case of Danon disease. J Cardiovasc Magn Reson 2009; 11: 12.
8. Tada H, Harimura Y, Yamasaki H, Sekiguchi Y, Ishizu T, Seo Y, Kawano S, Aonuma K: Utility of real-time 3-dimensional echocardiography and magnetic resonance imaging for evaluation of Danon disease. Circulation 2010; 121:e390-e392.
9. Dara BS, Rusconi PG, Fishman JE: Danon disease: Characteristic late gadolinium enhancement pattern on cardiac magnetic resonance imaging. Cardiol Young 2011; 21: 707-709.
10. Choi EY, Choi BW, Kim SA, Rhee SJ, Shim CY, Kim YJ, Kang SM, Ha JW, Chung N: Patterns of late gadolinium enhancement are associated with ventricular stiffness in patients with adVanced non-ischaemic dilated cardiomyopathy. Eur J Heart Fail 2009; 11: 573-580.
11. Syed IS, Glockner JF, Feng D, Araoz PA, Martinez MW, Edwards WD, Gertz MA, Dispenzieri A, Oh JK, Bellavia D, Tajik AJ, Grogan M: Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis. JACC Cardiovasc Imaging 2010; 3: 155-164.
12. Patel MR, Cawley PJ, Heitner JF, Klem I, Parker MA, Jaroudi WA, Meine TJ, White JB, Elliott MD, Kim HW, Judd RM, Kim RJ: Detection of myocardial damage in patients with sarcoidosis. Circulation 2009; 120: 1969-1977.
13. De Cobelli F, Esposito A, Belloni E, Pieroni M, Perseghin G, Chimenti C, Frustaci A, Del Maschio A: Delayed-enhanced cardiac MRI for differentiation of Fabry's disease from symmetric hypertrophic cardiomyopathy. AJR Am J Roentgenol 2009; 192:W97-W102.